JP2019216683A - Tablet and manufacturing method therefor - Google Patents

Tablet and manufacturing method therefor Download PDF

Info

Publication number
JP2019216683A
JP2019216683A JP2018118840A JP2018118840A JP2019216683A JP 2019216683 A JP2019216683 A JP 2019216683A JP 2018118840 A JP2018118840 A JP 2018118840A JP 2018118840 A JP2018118840 A JP 2018118840A JP 2019216683 A JP2019216683 A JP 2019216683A
Authority
JP
Japan
Prior art keywords
water
tablet
powder
chitosan
mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018118840A
Other languages
Japanese (ja)
Other versions
JP6982552B2 (en
Inventor
洋介 一宮
Yosuke Ichinomiya
洋介 一宮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dainichiseika Color and Chemicals Mfg Co Ltd
Original Assignee
Dainichiseika Color and Chemicals Mfg Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainichiseika Color and Chemicals Mfg Co Ltd filed Critical Dainichiseika Color and Chemicals Mfg Co Ltd
Priority to JP2018118840A priority Critical patent/JP6982552B2/en
Publication of JP2019216683A publication Critical patent/JP2019216683A/en
Application granted granted Critical
Publication of JP6982552B2 publication Critical patent/JP6982552B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

To provide a tablet mainly containing an insoluble dietary fiber such as chitosan, capable of being dispersed in water quickly while maintaining hardness of a fixed value or more, and a manufacturing method therefor.SOLUTION: There is provided a tablet containing a powder component of at least one of chitin and chitosan, having percentage of the powder component in all solid components of 10 mass% or more, particle size of the powder component passing sieves with 80 mesh, and hardness of 8 to 30 kgf. A water-containing raw material obtained by mixing the powder component and water is dried and classified to obtain a dried powder having water content of 15 mass% or less, and a mold raw material containing the obtained dried powder is tabled molded.SELECTED DRAWING: None

Description

本発明は、一定以上の硬度を保ちながらも水中で素早く分散しうる錠剤、及びその製造方法に関する。   The present invention relates to a tablet which can be rapidly dispersed in water while maintaining a certain hardness or more, and a method for producing the tablet.

有効成分を含む粉末を錠剤成型して得られる錠剤については、輸送時や保管時に包装内で割れ、欠け、摩損等の不具合が生じないように、一定以上の硬度を有することが求められている。さらに、錠剤に対しては、水中において適切な時間内で分散する分散性を有することも求められている。しかしながら、錠剤の硬度と分散性は、いわゆるトレードオフの関係にあるため、両立させることは一般的には困難であるとされている。   Tablets obtained by tableting a powder containing the active ingredient are required to have a certain hardness or more so that cracks, chips, and abrasion do not occur in the package during transportation or storage. . Further, tablets are also required to have dispersibility that disperses in water within an appropriate time. However, hardness and dispersibility of tablets are in a so-called trade-off relationship, and it is generally considered difficult to achieve both.

キトサン等の多くの食物繊維の形状は繊維状であるために、粉体流動性が悪く、そのままでの状態では錠剤にすることが困難である。また、キトサンは嵩比重が小さいため、キトサンの充填量には限界があるとともに、得られる錠剤は摩損しやすくなる傾向にある。したがって、キトサン等の食物繊維を含有する錠剤を成型するには、通常、タルク、ステアリン酸マグネシウム、ショ糖脂肪酸エステルなどの滑沢剤を添加するか、又は結晶乳糖、結晶セルロースなどの流動性のよい賦型剤と混合して打錠する。しかし、滑沢剤などの他の成分と混合して成型すれば、食物繊維の含有量が少なくなる。このため、流動性を高めつつ、得られる錠剤中の食物繊維の量を増やすことが可能な錠剤の製造方法の開発が望まれていた。   Since many dietary fibers such as chitosan are fibrous in shape, powder fluidity is poor, and it is difficult to make tablets as they are. In addition, since chitosan has a low bulk specific gravity, the amount of chitosan to be filled is limited, and the obtained tablets tend to be easily worn out. Therefore, to mold tablets containing dietary fiber such as chitosan, usually, a lubricant such as talc, magnesium stearate, sucrose fatty acid ester, or crystalline lactose, crystalline cellulose and other fluidity Mix with good excipients and tablet. However, if it is mixed with other components such as a lubricant and molded, the content of dietary fiber is reduced. Therefore, development of a tablet manufacturing method capable of increasing the amount of dietary fiber in the obtained tablet while increasing the fluidity has been desired.

従来、有効成分と、崩壊剤や賦形剤などの助剤成分との配合バランスを調整することで、一定以上の硬度と分散性を兼ね備えた錠剤製造することが検討されている。例えば、カルシウム素材を成型助剤として配合して硬度を高めた錠剤が提案されている(特許文献1)。また、カルシウム粉末素材及び結晶セルロースを配合し、打錠して得られる、硬度及び崩壊性を改良したキトサン含有錠剤が提案されている(特許文献2)。さらに、炭酸カルシウム、セルロース、及びサポニンを所定の比率で配合した、崩壊性に優れたキトサン含有錠剤が提案されている(特許文献3)。さらに、N−アセチルグルコサミンを30〜90質量%含有する口腔内崩壊型の錠剤(特許文献4)や、キトサン、カルシウム素材、及び有機酸を含む錠剤(特許文献5)が提案されている。   Conventionally, it has been studied to manufacture tablets having both a certain degree of hardness and dispersibility by adjusting the mixing balance between the active ingredient and auxiliary components such as disintegrants and excipients. For example, a tablet in which a calcium material is blended as a molding aid to increase hardness has been proposed (Patent Document 1). In addition, a chitosan-containing tablet having improved hardness and disintegrability, which is obtained by blending a calcium powder material and crystalline cellulose and compressing the same, has been proposed (Patent Document 2). Further, a chitosan-containing tablet excellent in disintegration, in which calcium carbonate, cellulose and saponin are blended at a predetermined ratio, has been proposed (Patent Document 3). Further, an orally disintegrating tablet containing 30 to 90% by mass of N-acetylglucosamine (Patent Document 4) and a tablet containing chitosan, a calcium material, and an organic acid (Patent Document 5) have been proposed.

特許第4132870号公報Japanese Patent No. 4132870 特開2004−262860号公報JP 2004-262860 A 特許第4824213号公報Japanese Patent No. 4824213 特許第4403182号公報Japanese Patent No. 4403182 特許第3737881号公報Japanese Patent No. 3737781

しかしながら、特許文献1及び2で提案された錠剤は、いずれもある程度の硬度を有するものの、崩壊性が未だ不十分であり、さらなる改良の余地があった。また、これらの錠剤を製造するには有効成分以外の特定の成分を成型助剤として配合する必要があるため、有効成分の含有量が相対的に減少する傾向にあるといった課題もあった。さらに、特許文献3においては、得られる錠剤の硬度については何ら検討されていない。また、特許文献4においては咀嚼時における錠剤の崩壊時間について検討されているが、水中での崩壊性については何ら検討されていない。さらに、特許文献5で提案された錠剤は、有機酸とカルシウム素材をキトサン以外の成分として含むため、キトサンの含有量が少ないものであった。   However, although the tablets proposed in Patent Documents 1 and 2 each have a certain degree of hardness, the disintegration is still insufficient, and there is room for further improvement. In addition, in order to produce these tablets, it is necessary to mix a specific component other than the active ingredient as a molding aid, so that there is also a problem that the content of the active ingredient tends to relatively decrease. Further, Patent Document 3 does not discuss the hardness of the obtained tablet at all. Patent Document 4 discusses the disintegration time of tablets during chewing, but does not discuss disintegration in water. Furthermore, since the tablet proposed in Patent Document 5 contains an organic acid and a calcium material as components other than chitosan, the content of chitosan is small.

本発明は、このような従来技術の有する問題点に鑑みてなされたものであり、その課題とするところは、一定以上の硬度を保ちながらも水中で速やかに分散しうる、キトサン等の不溶性食物繊維を主成分とする錠剤、及びその製造方法を提供することにある。   The present invention has been made in view of such problems of the prior art, and an object thereof is to provide an insoluble food such as chitosan that can be rapidly dispersed in water while maintaining a certain degree of hardness. An object of the present invention is to provide a tablet containing fibers as a main component and a method for producing the tablet.

すなわち、本発明によれば、以下に示す錠剤が提供される。
[1]キチン及びキトサンの少なくともいずれかの粉末成分を含有するとともに、全固形分に占める前記粉末成分の割合が10質量%以上であり、前記粉末成分の粒度が、80メッシュの篩をパスする粒度であり、硬度が8〜30kgfである錠剤。
[2]前記粉末成分が、脱アセチル化度が70%以上のキトサンの粉末である前記[1]に記載の錠剤。
[3]前記粉末成分が、セルロースの粉末をさらに含む前記[1]又は[2]に記載の錠剤。
[4]賦形剤及び滑沢剤の少なくともいずれかをさらに含有する前記[1]〜[3]のいずれかに記載の錠剤。
[5]経口用錠剤である前記[1]〜[4]のいずれかに記載の錠剤。
[6]撹拌状態の37℃の水に投入してから、その原形を目視により観察できなくなるまでの時間が、120秒以内である前記[1]〜[5]のいずれかに記載の錠剤。
That is, according to the present invention, the following tablets are provided.
[1] A powder component containing at least one of chitin and chitosan is contained, the ratio of the powder component to the total solid content is 10% by mass or more, and the particle size of the powder component passes through a sieve of 80 mesh. Tablets having a particle size and a hardness of 8 to 30 kgf.
[2] The tablet according to [1], wherein the powder component is a chitosan powder having a degree of deacetylation of 70% or more.
[3] The tablet according to the above [1] or [2], wherein the powder component further contains a cellulose powder.
[4] The tablet according to any of [1] to [3], further comprising at least one of an excipient and a lubricant.
[5] The tablet according to any one of [1] to [4], which is an oral tablet.
[6] The tablet according to any one of the above [1] to [5], wherein a time from being poured into water at 37 ° C. in a stirring state until the original form cannot be visually observed is 120 seconds or less.

また、本発明によれば、以下に示す錠剤の製造方法が提供される。
[7]前記[1]〜[6]のいずれかに記載の錠剤の製造方法であって、80メッシュの篩をパスする粒度である、キチン及びキトサンの少なくともいずれかの粉末成分と水を混合し、下記式(1)で表される水添加率が200〜400質量%である含水原料を得る工程と、得られた前記含水原料を乾燥及び分級して、含水率が15質量%以下である乾燥粉末を得る工程と、得られた前記乾燥粉末を含有する成型原料を成型して錠剤を得る工程と、
を有する錠剤の製造方法。
水添加率(質量%)=(W/P)×100 ・・・(1)
P:粉末成分の量(g)
W:添加する水の量(g)
[8]前記粉末成分と前記水を混合した後、加熱条件下で撹拌して前記含水原料を得る前記[7]に記載の錠剤の製造方法。
Further, according to the present invention, there is provided a method for producing a tablet described below.
[7] The method for producing a tablet according to any one of [1] to [6], wherein a powder component of at least one of chitin and chitosan having a particle size passing an 80-mesh sieve is mixed with water. Then, a step of obtaining a water-containing raw material having a water addition rate represented by the following formula (1) of 200 to 400% by mass, and drying and classifying the obtained water-containing raw material so that the water content is 15% by mass or less. A step of obtaining a certain dry powder, and a step of molding a molding material containing the obtained dry powder to obtain a tablet,
A method for producing a tablet having:
Water addition rate (% by mass) = (W / P) × 100 (1)
P: amount of powder component (g)
W: amount of water to be added (g)
[8] The method for producing a tablet according to [7], wherein after mixing the powder component and the water, the mixture is stirred under a heating condition to obtain the water-containing raw material.

本発明によれば、一定以上の硬度を保ちながらも水中で速やかに分散しうる、キトサン等の不溶性食物繊維を主成分とする錠剤、及びその製造方法を提供することができる。   ADVANTAGE OF THE INVENTION According to this invention, the tablet containing insoluble dietary fiber, such as chitosan, which can be rapidly disperse | distributed in water, maintaining the hardness more than fixed, and its manufacturing method can be provided.

<錠剤>
以下、本発明の実施の形態について説明するが、本発明は以下の実施の形態に限定されるものではない。本発明の錠剤は、キチン及びキトサンの少なくともいずれかの粉末成分を含有するとともに、全固形分に占める粉末成分の割合が10質量%以上である。以下、その詳細について説明する。
<Tablets>
Hereinafter, embodiments of the present invention will be described, but the present invention is not limited to the following embodiments. The tablet of the present invention contains at least one powder component of chitin and chitosan, and the ratio of the powder component to the total solid content is 10% by mass or more. Hereinafter, the details will be described.

(粉末成分)
本発明の錠剤に用いる粉末成分は、キチン及びキトサンの少なくともいずれかである。キチンは、2−アセトアミド−2−デオキシ−D−グルコース(N−アセチルグルコサミン)を構成単位とする塩基性多糖類(β−(1→4)−2−アセトアミド−2−デオキシ−β−D−グルコース)である。また、キトサンはキチンの脱アセチル化物であり、2−アミノ−2−デオキシ−D−グルコース(グルコサミン)を構成単位とする塩基性多糖類(β−(1→4)−2−アミノ−2−デオキシ−β−D−グルコース)である。また、本発明の錠剤に用いる粉末成分は、セルロースの粉末をさらに含むことが好ましい。キチン、キトサン、及びセルロースは、いずれも工業的に生産されており、種々のグレードのものをそれぞれ入手することができる。本発明においては、キチン及びキトサンの少なくともいずれかを用いることが、脂肪吸収阻害効果、降コレステロール作用、血圧低下効果、血中尿酸レベル低下効果、重金属吸着能等の種々の生理活性を錠剤に付与しうるために好ましい。
(Powder component)
The powder component used in the tablet of the present invention is at least one of chitin and chitosan. Chitin is a basic polysaccharide (β- (1 → 4) -2-acetamido-2-deoxy-β-D-) having 2-acetamido-2-deoxy-D-glucose (N-acetylglucosamine) as a structural unit. Glucose). Chitosan is a deacetylated product of chitin, and is a basic polysaccharide (β- (1 → 4) -2-amino-2- having 2-amino-2-deoxy-D-glucose (glucosamine) as a structural unit. Deoxy-β-D-glucose). The powder component used in the tablet of the present invention preferably further contains cellulose powder. Chitin, chitosan, and cellulose are all industrially produced, and various grades are available. In the present invention, the use of at least one of chitin and chitosan imparts various physiological activities to the tablet, such as a fat absorption inhibitory effect, a cholesterol lowering effect, a blood pressure lowering effect, a blood uric acid level lowering effect, and a heavy metal adsorption ability. It is preferable because it can be performed.

キチン及びキトサンは、食物繊維、LDLコレステロール値低減、及び尿酸値低減などの機能を発揮しうる有効成分であり、いわゆる不溶性食物繊維である。キチン及びキトサンの重量平均分子量については特に限定されない。キチン及びキトサンの重量平均分子量は、例えば、7,000〜3,000,000であることが好ましく、10,000〜2,000,000であることがさらに好ましい。但し、食物繊維、LDLコレステロール値低減、及び尿酸値低減などの機能をより有効に発揮させるには、キチン及びキトサンの分子量は大きい方が好ましい。特に、消化管内で老廃物、胆汁酸、尿酸等と吸着して機能を発揮させる場合には、水に溶けない程度の分子量のキチン及びキトサンを用いることが好ましい。   Chitin and chitosan are active ingredients that can exert functions such as dietary fiber, LDL cholesterol level reduction, and uric acid level reduction, and are so-called insoluble dietary fiber. The weight average molecular weight of chitin and chitosan is not particularly limited. The weight average molecular weight of chitin and chitosan is, for example, preferably from 7,000 to 3,000,000, and more preferably from 10,000 to 2,000,000. However, it is preferable that the molecular weights of chitin and chitosan are large in order to more effectively exert functions such as reduction of dietary fiber, LDL cholesterol level, and uric acid level. In particular, in the case of exhibiting a function by adsorbing waste products, bile acids, uric acid and the like in the digestive tract, it is preferable to use chitin and chitosan having a molecular weight that is insoluble in water.

粉末成分としては、キトサンを用いることがさらに好ましい。キトサンの脱アセチル化度は、70%以上であることが好ましく、75〜99%であることがさらに好ましい。脱アセチル化度が70%以上のキトサンを用いると、食物繊維、LDLコレステロール値低減、及び尿酸値低減などの機能をより有効に発揮させることができる。   More preferably, chitosan is used as the powder component. The degree of deacetylation of chitosan is preferably 70% or more, and more preferably 75 to 99%. When chitosan having a degree of deacetylation of 70% or more is used, functions such as reduction of dietary fiber, LDL cholesterol level, and uric acid level can be more effectively exhibited.

キトサンの脱アセチル化度は、コロイド滴定を行い、その滴定量から算出することができる。具体的には、指示薬にトルイジンブルー溶液を用い、ポリビニル硫酸カリウム水溶液でコロイド滴定することにより、キトサン分子中の遊離アミノ基を定量し、キトサンの脱アセチル化度を求める。脱アセチル化度の測定方法の一例を以下に示す。   The degree of deacetylation of chitosan can be calculated from colloid titration and the titer. Specifically, by using a toluidine blue solution as an indicator and performing colloid titration with an aqueous solution of polyvinyl potassium sulfate, the amount of free amino groups in the chitosan molecule is determined, and the degree of deacetylation of chitosan is determined. One example of a method for measuring the degree of deacetylation is shown below.

(1)滴定試験
0.5質量%酢酸水溶液にキトサン純分濃度が0.5質量%となるようにキトサンを添加し、キトサンを撹拌及び溶解して100gの0.5質量%キトサン/0.5質量%酢酸水溶液を調製する。次に、この溶液10gとイオン交換水90gを撹拌混合して、0.05質量%のキトサン溶液を調製する。さらに、この0.05質量%キトサン溶液10gにイオン交換水50mL、トルイジンブルー溶液約0.2mLを添加して試料溶液を調製し、ポリビニル硫酸カリウム溶液(N/400PVSK)にて滴定する。滴定速度は2〜5ml/分とし、試料溶液が青から赤紫色に変色後、30秒間以上保持する点を終点の滴定量とする。なお、キトサン純分とは、原料キトサン試料中のキトサンの質量を意味する。具体的には、原料キトサン試料を105℃で2時間乾燥して求められる固形分質量である。
(1) Titration test Chitosan was added to a 0.5% by mass aqueous acetic acid solution so that the pure concentration of chitosan was 0.5% by mass, and the chitosan was stirred and dissolved to obtain 100 g of 0.5% by mass of chitosan / 0.1% by mass. A 5% by mass aqueous acetic acid solution is prepared. Next, 10 g of this solution and 90 g of ion-exchanged water are stirred and mixed to prepare a 0.05% by mass chitosan solution. Further, 50 mL of ion-exchanged water and about 0.2 mL of toluidine blue solution are added to 10 g of the 0.05% by mass chitosan solution to prepare a sample solution, and titrated with a polyvinyl potassium sulfate solution (N / 400 PVSK). The titration rate is 2 to 5 ml / min, and the point at which the sample solution is changed from blue to magenta and held for 30 seconds or more is defined as the titration amount at the end point. In addition, chitosan pure content means the mass of chitosan in a raw material chitosan sample. Specifically, it is the solid content mass obtained by drying the raw material chitosan sample at 105 ° C. for 2 hours.

(2)空試験
上記の滴定試験に使用した0.5質量%キトサン/0.5質量%酢酸水溶液に代えて、イオン交換水を使用し、同様の滴定試験を行う。
(2) Blank test A similar titration test is performed using ion-exchanged water instead of the 0.5% by mass chitosan / 0.5% by mass acetic acid aqueous solution used in the above titration test.

(3)アセチル化度の計算
X=1/400×161×f×(V−B)/1000
=0.4025×f×(V−B)/1000
Y=0.5/100−X
X:キトサン中の遊離アミノ基質量(グルコサミン残基質量に相当)
Y:キトサン中の結合アミノ基質量(N−アセチルグルコサミン残基質量に相当)
f:N/400PVSKの力価
V:試料溶液の滴定量(mL)
B:空試験滴定量(mL)
脱アセチル化度(%)
=(遊離アミノ基)/{(遊離アミノ基)+(結合アミノ基)}×100
=(X/161)/(X/161+Y/203)×100
なお、「161」はグルコサミン残基の分子量、「203」はN−アセチルグルコサミン残基の分子量である。
(3) Calculation of degree of acetylation X = 1/400 × 161 × f × (V−B) / 1000
= 0.4025 × f × (V−B) / 1000
Y = 0.5 / 100-X
X: Free amino group mass in chitosan (corresponding to glucosamine residue mass)
Y: Mass of bound amino group in chitosan (corresponding to mass of N-acetylglucosamine residue)
f: titer of N / 400 PVSK V: titer of sample solution (mL)
B: Blank test titer (mL)
Deacetylation degree (%)
= (Free amino group) / {(free amino group) + (bonded amino group)} × 100
= (X / 161) / (X / 161 + Y / 203) × 100
“161” is the molecular weight of a glucosamine residue, and “203” is the molecular weight of an N-acetylglucosamine residue.

本発明の錠剤に含まれる全固形分に占める粉末成分の割合は、10質量%以上であり、好ましくは30質量%以上、さらに好ましくは60質量%以上である。全固形分に占める粉末成分の割合が10質量%未満であると、キトサン等の有効成分の錠剤中の量が少ない。なお、錠剤中の全固形分に占めるキトサン等の粉末成分の割合の上限については特に限定されず、100質量%(すなわち、固形分のすべてがキトサン等の粉末成分)であってもよい。   The ratio of the powder component to the total solid content contained in the tablet of the present invention is 10% by mass or more, preferably 30% by mass or more, and more preferably 60% by mass or more. When the ratio of the powder component to the total solid content is less than 10% by mass, the amount of the active ingredient such as chitosan in the tablet is small. The upper limit of the ratio of the powder component such as chitosan to the total solid content in the tablet is not particularly limited, and may be 100% by mass (that is, all solid components are powder components such as chitosan).

粉末成分の粒度は、80メッシュの篩をパスする粒度(80メッシュパス)であり、好ましくは100メッシュの篩をパスする粒度(100メッシュパス)である。80メッシュの篩をパスしない粒度(80メッシュオン)の粉末成分を用いると、錠剤成型しにくくなり、得られる錠剤の硬度が低下する。なお、篩の「メッシュ」は、1平方インチ当たりの篩の目の数を意味し、JIS Z 8801:2006に規定されている標準篩によるものである。粉末成分の粒度は、特定の目開きのメッシュを備えた振動篩機を使用して篩い分けすることで適宜調整することができる。   The particle size of the powder component is a particle size that passes through an 80 mesh sieve (80 mesh pass), and preferably a particle size that passes through a 100 mesh sieve (100 mesh pass). When a powder component having a particle size (80 mesh on) that does not pass through an 80 mesh sieve is used, it becomes difficult to form a tablet, and the hardness of the obtained tablet decreases. The "mesh" of the sieve means the number of sieve meshes per square inch, and is based on a standard sieve specified in JIS Z 8801: 2006. The particle size of the powder component can be appropriately adjusted by sieving using a vibrating sieve equipped with a specific mesh.

(その他の成分)
本発明の錠剤は、上記の粉末成分以外の成分(その他の成分)を含有してもよい。その他の成分としては、賦形剤、滑沢剤、結合剤、崩壊剤、着色剤、着香剤、矯味剤、矯臭剤、乳化剤、分散剤、防腐剤などの、一般的な錠剤を構成するために用いられる各種成分を挙げることができる。
(Other components)
The tablet of the present invention may contain components (other components) other than the above-mentioned powder component. Other components include common tablets such as excipients, lubricants, binders, disintegrants, colorants, flavors, flavors, odorants, emulsifiers, dispersants, and preservatives. Components used for this purpose.

賦形剤としては、例えば、結晶セルロース、プルラン、ブドウ糖、グアーガム、キサンタンガム、ソルビトール、マンニトール、澱粉、デキストリン、乳糖、還元麦芽糖、エリスリトール、キシリトール、アルギン酸ナトリウム、メチルセルロース、エチルセルロース、アラビアガム、ヒドロキシプロピルメチルセルロースフタレートなどを挙げることができる。また、水と混合する前のキチン粉砕物やキトサン粉砕物を賦形剤として使用することもできる。キトサン粉砕物等を打錠すると、繊維の絡まりによって硬度が非常に高くなる。このため、そのような特性を生かし、キトサン粉砕物等を賦形剤として利用することができる。具体的には、水と混合した後に乾燥したキトサン処理物等と、水と混合していないキトサン粉砕物等を混合することで、得られる錠剤の硬度と水中分散性のバランスを制御することができる。   Excipients include, for example, crystalline cellulose, pullulan, glucose, guar gum, xanthan gum, sorbitol, mannitol, starch, dextrin, lactose, reduced maltose, erythritol, xylitol, sodium alginate, methylcellulose, ethylcellulose, gum arabic, hydroxypropylmethylcellulose phthalate And the like. In addition, a chitin crushed product or a chitosan crushed product before mixing with water can also be used as an excipient. When a chitosan crushed product or the like is tableted, the hardness becomes extremely high due to entanglement of fibers. For this reason, by utilizing such properties, pulverized chitosan can be used as an excipient. Specifically, by mixing a chitosan-treated product or the like dried after mixing with water and a pulverized chitosan not mixed with water, it is possible to control the balance between the hardness of the obtained tablet and the dispersibility in water. it can.

滑沢剤としては、例えば、卵殻粉末、ショ糖脂肪酸エステル、ステアリン酸、ステアリン酸マグネシウム、ステアリン酸アルミニウム、ステアリン酸カルシウム、タルク、ポリビニルピロリドン、植物硬化油などを挙げることができる。   Examples of the lubricant include eggshell powder, sucrose fatty acid ester, stearic acid, magnesium stearate, aluminum stearate, calcium stearate, talc, polyvinylpyrrolidone, and vegetable hardened oil.

さらに、上記成分の他、必要に応じて、水溶性ビタミン(ビタミンB1、B2、B6、B12、C等)、脂溶性ビタミン(ビタミンA、D、E等)、コラーゲン、イチョウ葉エキス、オリゴ糖、アセロラエキス、アロエエキス、ローヤルゼリー、アセトアミノフェン、アセチルサリチル酸、イブプロフェン、トラマドール、ベンズブロマロン、プロベネシド、スルフィンピラゾン、ブコローム、ロサルタン、バルサルタン、テルミサルタン、オルメサルタン、イルベサルタン、アジルサルタン、メフェナム酸、カンデサルタン等を配合することもできる。   Furthermore, in addition to the above components, if necessary, water-soluble vitamins (such as vitamins B1, B2, B6, B12, and C), fat-soluble vitamins (such as vitamins A, D, and E), collagen, ginkgo biloba extract, and oligosaccharides , Acerola extract, aloe extract, royal jelly, acetaminophen, acetylsalicylic acid, ibuprofen, tramadol, benzbromarone, probenecid, sulfinpyrazone, bucolome, losartan, valsartan, telmisartan, olmesartan, irbesartan, azilsartan, mefenamic acid, candesartan, etc. Can also be blended.

また、錠剤成型後にセラック等のコーティング剤を用いてコーティングし、コーティング錠剤としてもよい。コーティング剤の量は特に限定されないが、錠剤に対して0.1〜2.0質量%とすることが好ましい。コーティング方法としては、コーティング剤を錠剤に噴霧して乾燥させる方法や、糖衣機などを使用する方法などがある。   Alternatively, the tablet may be coated with a coating agent such as shellac after tablet molding to obtain a coated tablet. The amount of the coating agent is not particularly limited, but is preferably 0.1 to 2.0% by mass based on the tablet. Examples of the coating method include a method in which a coating agent is sprayed on tablets and dried, and a method using a sugar coating machine or the like.

<錠剤の製造方法>
次に、上述の錠剤の製造方法について説明する。本発明の錠剤の製造方法は、80メッシュの篩をパスする粒度である、キチン及びキトサンの少なくともいずれかの粉末成分と水を混合し、下記式(1)で表される水添加率が200〜400質量%である含水原料を得る工程(工程(1))と、得られた含水原料を乾燥及び分級して、含水率が15質量%以下である乾燥粉末を得る工程(工程(2))と、得られた乾燥粉末を含有する成型原料を成型して錠剤を得る工程(工程(3))と、を有する。以下、その詳細について説明する。
水添加率(質量%)=(W/P)×100 ・・・(1)
P:粉末成分の量(g)
W:添加する水の量(g)
<Tablet manufacturing method>
Next, a method for producing the above-mentioned tablet will be described. According to the tablet manufacturing method of the present invention, water is mixed with at least one powder component of chitin and chitosan, which has a particle size passing an 80-mesh sieve, and water is added. A step of obtaining a water-containing raw material having a water content of 15% by mass or less (step (1)); and a step of drying and classifying the obtained water-containing raw material to obtain a dry powder having a water content of 15% by mass or less (step (2)). ) And a step of molding a molding material containing the obtained dry powder to obtain a tablet (step (3)). Hereinafter, the details will be described.
Water addition rate (% by mass) = (W / P) × 100 (1)
P: amount of powder component (g)
W: amount of water to be added (g)

(工程(1))
工程(1)では、その粒度が80メッシュパスである粉末成分と水を混合し、水添加率が200〜400質量%である含水原料を得る。粉末成分と水を混合することで、粉末成分(キトサン粒子、キチン粒子)の粒子表面を処理することができる。これにより、最終的に得られる錠剤の分散性を向上させることができる。なお、80メッシュオンの粉末成分を用いると、成型が困難になる。また、工程(1)や、後述する工程(2)を実施することなく、キチンやキトサンの粗体をカッターミルやジェットミル等によって粉砕処理して得た粉末成分をそのまま用いて錠剤成型すると、得られる錠剤が水中で分散しにくくなり、分散時間が長くなる。
(Step (1))
In the step (1), a powder component having a particle size of 80 mesh pass and water are mixed to obtain a water-containing raw material having a water addition rate of 200 to 400% by mass. By mixing the powder component and water, the particle surface of the powder component (chitosan particles, chitin particles) can be treated. Thereby, the dispersibility of the finally obtained tablet can be improved. If a powder component of 80 mesh-on is used, molding becomes difficult. Further, without performing the step (1) or the step (2) described later, tableting is performed using the powder component obtained by pulverizing a crude body of chitin or chitosan by a cutter mill, a jet mill, or the like, as it is, The resulting tablets are less likely to disperse in water and the dispersing time is longer.

粉末成分と水を混合して得る含水原料の水添加率は200〜400質量%であり、好ましくは300〜400質量%である。含水原料の水添加率が200質量%未満であると、錠剤の硬度と水分散性のバランスをとることが困難になる。特に、含水原料の水添加率が100質量%以上200質量%未満であると、得られる錠剤の硬度が高くならない。一方、含水原料の水添加率が400質量%超であると、粉末成分と水を含む混合物がひと纏まりになりやすいため、作業性が低下する。   The water content of the water-containing raw material obtained by mixing the powder component and water is 200 to 400% by mass, and preferably 300 to 400% by mass. If the water content of the water-containing raw material is less than 200% by mass, it becomes difficult to balance the hardness of the tablet with the water dispersibility. In particular, when the water content of the water-containing raw material is 100% by mass or more and less than 200% by mass, the hardness of the obtained tablet does not increase. On the other hand, when the water addition ratio of the water-containing raw material is more than 400% by mass, the mixture containing the powder component and water tends to be united, so that the workability is reduced.

粉末成分と水を混合するには、混合機を用いることができる。混合機の種類は特に限定されないが、例えば、ニーダー、円筒型混合機、V型混合機、スクリュー型混合機などを用いることができる。   A mixer can be used to mix the powder component with water. Although the type of the mixer is not particularly limited, for example, a kneader, a cylindrical mixer, a V-type mixer, a screw-type mixer, and the like can be used.

粉末成分と水を混合した後には、加熱条件下で撹拌して含水原料を得ることが好ましい。加熱温度は特に制限されないが、80℃以下とすることが好ましい。粉末成分と水を含む混合物を加熱条件下で撹拌すると、非加熱条件下で撹拌する場合と比べて、錠剤成型時に一定の硬度を保持し、かつ、水中で速やかに分散する錠剤特性を短時間で付与することが可能である。   After mixing the powder component and water, it is preferable to obtain a water-containing raw material by stirring under heating conditions. The heating temperature is not particularly limited, but is preferably 80 ° C. or lower. When a mixture containing a powder component and water is stirred under heating conditions, compared with stirring under non-heating conditions, a certain hardness is maintained at the time of tablet molding, and the tablet characteristics of rapidly dispersing in water are reduced in a short time. Can be provided.

(工程(2))
工程(2)では、工程(1)で得た含水原料を乾燥及び分級して乾燥粉末を得る。乾燥粉末の含水率は15質量%以下、好ましくは12質量%以下、さらに好ましくは10質量%以下とする。含水原料を乾燥して得られる乾燥粉末の含水率が15質量%超であると、長期保管した際に、メイラード反応等による着色及び低分子化反応が起こりやすくなる。
(Step (2))
In step (2), the water-containing raw material obtained in step (1) is dried and classified to obtain a dry powder. The water content of the dry powder is 15% by mass or less, preferably 12% by mass or less, more preferably 10% by mass or less. When the water content of the dry powder obtained by drying the water-containing raw material is more than 15% by mass, coloring and a low-molecular-weight reaction due to a Maillard reaction or the like easily occur during long-term storage.

含水原料は、加熱条件下で乾燥してもよく、減圧条件下で乾燥してもよい。また、混合しながら乾燥してもよいし、混合機から取り出して静置状態で乾燥してもよい。含水原料を加熱条件下で乾燥すると、非加熱条件下で乾燥する場合と比べて、乾燥時間を短縮することができるために好ましい。   The water-containing raw material may be dried under heating conditions, or may be dried under reduced pressure conditions. Moreover, you may dry while mixing, and may take out from a mixer and dry in a stationary state. Drying the water-containing raw material under heating conditions is preferable because the drying time can be reduced as compared with the case of drying under non-heating conditions.

(工程(3))
工程(3)では、工程(2)で得た乾燥粉末を含有する成型原料を成型する。これにより、本発明の錠剤を得ることができる。乾燥粉末のみを成型原料として用いてもよく、乾燥粉末とその他の成分を配合して成型原料を調製してもよい。その他の成分としては、賦形剤、滑沢剤、結合剤、崩壊剤、着色剤、着香剤、矯味剤、矯臭剤、乳化剤、分散剤、補助剤、防腐剤、緩衝剤などの、一般的な錠剤を構成するための前述の各種成分を用いることができる。また、錠剤は、打錠機などの錠剤成型機を用いる一般的な錠剤成型法により成型原料を打錠することによって製造することができる。
(Step (3))
In the step (3), a molding raw material containing the dry powder obtained in the step (2) is molded. Thereby, the tablet of the present invention can be obtained. The dry powder alone may be used as a molding material, or the molding material may be prepared by blending the dry powder and other components. Other ingredients include general ingredients such as excipients, lubricants, binders, disintegrants, colorants, flavors, flavors, odorants, emulsifiers, dispersants, adjuvants, preservatives, and buffers. The various components described above for constituting a typical tablet can be used. In addition, tablets can be produced by tableting raw materials for molding by a general tablet molding method using a tablet molding machine such as a tableting machine.

(錠剤の物性)
上記の製造方法によって製造される本発明の錠剤(例えば、乾燥粉末を含有する成型原料を、圧縮機を用いて2tfの圧縮圧で成型して得られる、直径8mm、200mgの円柱形状の錠剤)の硬度(錠剤硬度)は、8〜30kgfであり、好ましくは10kgf以上である。すなわち、本発明の製造方法によって製造される錠剤は硬度が十分に高いため、輸送時や保管時に包装内で割れ、欠け、摩損等の不具合が発生しにくい。本明細書における錠剤の硬度(錠剤硬度)は、錠剤硬度計(例えば、商品名「モンサント錠剤硬度計 B型」、富士理化工業社製)を使用し、錠剤を水平方向に圧縮破断する際に要した荷重(単位;kgf)である。なお、各処方につき5回測定した平均値を錠剤硬度とした。
(Physical properties of tablets)
Tablets of the present invention produced by the above production method (for example, cylindrical tablets having a diameter of 8 mm and 200 mg, obtained by molding a molding material containing a dry powder under a compression pressure of 2 tf using a compressor). Has a hardness (tablet hardness) of 8 to 30 kgf, preferably 10 kgf or more. That is, since the tablet manufactured by the manufacturing method of the present invention has sufficiently high hardness, problems such as cracking, chipping, and abrasion hardly occur in the package during transportation or storage. The tablet hardness (tablet hardness) in the present specification is measured by using a tablet hardness tester (for example, trade name “Monsanto Tablet Hardness Tester Type B”, manufactured by Fuji Rika Kogyo Co., Ltd.) when compressing and breaking the tablet in the horizontal direction. Required load (unit: kgf). The average value measured five times for each prescription was defined as the tablet hardness.

上記の製造方法によって製造される本発明の錠剤の37℃の水中における分散時間は、好ましくは120秒以内であり、さらに好ましくは60秒以内、特に好ましくは30秒以内である。すなわち、本発明の製造方法によって製造される錠剤は、一定以上の硬度を保ちながらも水中で素早く分散しうる、分散性に優れたものである。このため、本発明の錠剤は、輸送時や保管時に包装内で割れ、欠け、摩損等の不具合が生じがたいとともに、水中での分散性が良好であるので、例えば、経口用錠剤、口腔内崩壊錠剤、チュアブル錠剤、分散錠剤、健康食品、農業用資材、家畜用飼料、化粧料、凝集剤等として好適である。なお、錠剤の分散時間は、以下に示す手順にしたがって測定される値(単位:秒)である。
[分散時間の測定]
100mLビーカーに37℃の水を約80mL入れ、2cmのマグネットスターラーにて400rpmの回転速度で撹拌しつつ、水面より2cmの高さから錠剤を投入する。錠剤が水と接触してから、膨潤及び分散し、錠剤の原形が目視で確認できなくなるまでの時間を5回測定し、その平均値を分散時間(単位:秒)とする。
The dispersion time of the tablet of the present invention produced by the above production method in water at 37 ° C. is preferably within 120 seconds, more preferably within 60 seconds, particularly preferably within 30 seconds. That is, the tablet produced by the production method of the present invention is excellent in dispersibility, which can be rapidly dispersed in water while maintaining a certain hardness or more. For this reason, the tablet of the present invention is unlikely to cause problems such as cracking, chipping, and abrasion in the package during transportation and storage, and has good dispersibility in water. It is suitable as disintegrating tablets, chewable tablets, dispersed tablets, health foods, agricultural materials, livestock feed, cosmetics, flocculants, and the like. The dispersion time of the tablet is a value (unit: second) measured according to the following procedure.
[Measurement of dispersion time]
About 80 mL of water at 37 ° C. is put into a 100 mL beaker, and tablets are charged from a height of 2 cm from the water surface while stirring at a rotation speed of 400 rpm with a 2 cm magnet stirrer. After the tablet comes into contact with water, it swells and disperses, and the time until the original form of the tablet cannot be visually confirmed is measured five times, and the average value is defined as the dispersion time (unit: second).

次に、実施例及び比較例を挙げて本発明を更に具体的に説明するが、本発明はこれらの実施例に限定されるものではない。以下、「部」及び「%」とあるのは、特に断りのない限り質量基準である。   Next, the present invention will be described more specifically with reference to examples and comparative examples, but the present invention is not limited to these examples. Hereinafter, “parts” and “%” are based on mass unless otherwise specified.

<粉末の調製>
(製造例1)
重量平均分子量100万、脱アセチル化度85%のキトサン粗体をジェットミルで粉砕し、100メッシュパス、含水率8%のキトサン粉末を得た。
<Preparation of powder>
(Production Example 1)
A crude chitosan having a weight average molecular weight of 1,000,000 and a deacetylation degree of 85% was pulverized by a jet mill to obtain a chitosan powder having a 100 mesh pass and a water content of 8%.

(製造例2)
重量平均分子量150万、脱アセチル化度91%のキトサン粗体をジェットミルで粉砕し、80メッシュパス、含水率7%のキトサン粉末を得た。
(Production Example 2)
A crude chitosan having a weight average molecular weight of 1.5 million and a deacetylation degree of 91% was pulverized with a jet mill to obtain a chitosan powder having an 80 mesh pass and a water content of 7%.

(製造例3)
重量平均分子量150万、脱アセチル化度91%のキトサン粗体をジェットミルで粉砕し、60メッシュパスであるとともに、80メッシュオンである(80メッシュの篩を通過しない)、含水率12%のキトサン粉末を得た。
(Production Example 3)
A chitosan crude having a weight-average molecular weight of 1.5 million and a deacetylation degree of 91% is pulverized by a jet mill, and has a 60-mesh pass and 80-mesh on (does not pass through an 80-mesh sieve), and has a water content of 12%. A chitosan powder was obtained.

(製造例4)
重量平均分子量150万、脱アセチル化度5%のキチン粗体をカッターミルで粉砕し、80メッシュパス、含水率9%のキチン粉末を得た。
(Production Example 4)
A crude chitin having a weight average molecular weight of 1.5 million and a degree of deacetylation of 5% was pulverized with a cutter mill to obtain a chitin powder having an 80 mesh pass and a water content of 9%.

(製造例5)
重量平均分子量100万のセルロース粗体をカッターミルで粉砕し、80メッシュパスのセルロース粉末を得た。得られたセルロース粉末100部及び水150部をニーダーに入れ、水添加率150%の含水原料を得た。ニーダーの蓋をした状態で80℃に加熱して1時間撹拌した後、蓋を開けた状態とし、80℃の加熱と撹拌を継続しながら乾燥させた。その後、80メッシュの篩で分級して、含水率7%のセルロース粉末を得た。
(Production Example 5)
A coarse cellulose having a weight average molecular weight of 1,000,000 was pulverized by a cutter mill to obtain a cellulose powder having an 80 mesh pass. 100 parts of the obtained cellulose powder and 150 parts of water were put into a kneader to obtain a water-containing raw material having a water addition rate of 150%. After heating to 80 ° C. and stirring for 1 hour with the lid of the kneader, the lid was opened and dried while heating and stirring at 80 ° C. were continued. Thereafter, the mixture was classified with an 80-mesh sieve to obtain a cellulose powder having a water content of 7%.

(製造例6)
製造例1で得たキトサン粉末100部及び水300部をニーダーに入れ、水添加率300%の含水原料を得た。ニーダーの蓋をした状態で80℃に加熱して1時間撹拌した後、ホーロー皿に取り出してインキュベーター内に静置した。80℃に加熱して乾燥させた後、80メッシュの篩で分級して、含水率9%のキトサン粉末を得た。
(Production Example 6)
100 parts of the chitosan powder obtained in Production Example 1 and 300 parts of water were put into a kneader to obtain a water-containing raw material having a water addition rate of 300%. After heating to 80 ° C. and stirring for 1 hour with the lid of the kneader covered, the mixture was taken out into an enamel dish and allowed to stand in an incubator. After drying by heating to 80 ° C., the mixture was classified with an 80-mesh sieve to obtain a chitosan powder having a water content of 9%.

(製造例7)
製造例2で得たキトサン粉末100部及び水350部をニーダーに入れ、水添加率350%の含水原料を得た。ニーダーの蓋をした状態で80℃に加熱して1時間撹拌した後、蓋を開けた状態とし、80℃の加熱と撹拌を継続しながら乾燥させた。その後、100メッシュの篩で分級して、含水率7%のキトサン粉末を得た。
(Production Example 7)
100 parts of the chitosan powder obtained in Production Example 2 and 350 parts of water were put into a kneader to obtain a water-containing raw material having a water addition rate of 350%. After heating to 80 ° C. and stirring for 1 hour with the lid of the kneader, the lid was opened and dried while heating and stirring at 80 ° C. were continued. Thereafter, the mixture was classified with a 100-mesh sieve to obtain a chitosan powder having a water content of 7%.

(製造例8)
製造例2で得たキトサン粉末100部及び水250部をビニール袋に入れ、水添加率250%の含水原料を得た。ビニール袋の口を締め、上下左右に15分間振って内容物を混合した後、ホーロー皿に取り出して減圧乾燥機内に静置した。加熱することなく減圧乾燥した後、100メッシュの篩で分級して、含水率8%のキトサン粉末を得た。
(Production Example 8)
100 parts of the chitosan powder obtained in Production Example 2 and 250 parts of water were put in a plastic bag to obtain a water-containing raw material having a water addition rate of 250%. After closing the mouth of the plastic bag and shaking it up, down, left, and right for 15 minutes to mix the contents, the mixture was taken out into an enamel dish and allowed to stand in a vacuum dryer. After drying under reduced pressure without heating, the mixture was classified with a 100-mesh sieve to obtain a chitosan powder having a water content of 8%.

(製造例9)
製造例4で得たキチン粉末100部及び水150部をビニール袋に入れ、水添加率150%の含水原料を得た。ビニール袋の口を締め、上下左右に15分間振って内容物を混合した後、ホーロー皿に取り出してインキュベーター内に静置した。80℃に加熱して乾燥させた後、80メッシュの篩で分級して、含水率10%のキトサン粉末を得た。
(Production Example 9)
100 parts of the chitin powder obtained in Production Example 4 and 150 parts of water were put in a plastic bag to obtain a water-containing raw material having a water addition rate of 150%. After closing the mouth of the plastic bag and shaking it up, down, left, and right for 15 minutes to mix the contents, the mixture was taken out into an enamel dish and allowed to stand in the incubator. After drying by heating to 80 ° C., the resultant was classified with an 80-mesh sieve to obtain a chitosan powder having a water content of 10%.

(製造例10)
製造例2で得たキトサン粉末100部及び水500部をニーダーに入れ、水添加率500%の含水原料を得た。ニーダーの蓋をした状態で撹拌したところ、キトサンペーストがニーダーの回転軸に集まってひと纏まりとなった。これにより、ハンドリング性が著しく低下し、回収困難な状態となった。
(Production Example 10)
100 parts of the chitosan powder obtained in Production Example 2 and 500 parts of water were put into a kneader to obtain a water-containing raw material having a water addition rate of 500%. When the mixture was stirred with the lid of the kneader, the chitosan paste gathered on the rotating shaft of the kneader and became a unit. As a result, the handling property was remarkably reduced, and it was difficult to collect.

(製造例11)
製造例3で得たキトサン粉末100部及び水350部をニーダーに入れ、水添加率350%の含水原料を得た。ニーダーの蓋をした状態で80℃に加熱して1時間撹拌した後、蓋を開けた状態とし、80℃の加熱と撹拌を継続しながら乾燥させて、含水率7%のキトサン粉末を得た。
(Production Example 11)
100 parts of the chitosan powder obtained in Production Example 3 and 350 parts of water were placed in a kneader to obtain a water-containing raw material having a water addition rate of 350%. After heating to 80 ° C. with the lid of the kneader covered and stirring for 1 hour, the lid was opened and dried while heating and stirring at 80 ° C. were continued to obtain a chitosan powder having a water content of 7%. .

<錠剤の製造>
(実施例1)
打錠機(商品名「HANDTAB−100」、市橋精機社製、杵臼の直径:8mm)を使用し、製造例6で得たキトサン粉末200mgに2tfの打錠圧をかけて打錠して、円柱型の錠剤を得た。
<Manufacture of tablets>
(Example 1)
Using a tableting machine (trade name “HANDTAB-100”, manufactured by Ichihashi Seiki Co., Ltd., diameter of punch and die: 8 mm), a tableting pressure of 2 tf was applied to 200 mg of the chitosan powder obtained in Production Example 6, and tableting was performed. A cylindrical tablet was obtained.

(実施例2〜6、参考例1、比較例1〜7)
表1−1〜1−2に示す種類及び量のキトサン粉末、キチン粉末、セルロース粉末、結晶セルロース(商品名「Comprecel」(伏見製薬所社製)、食品添加物)、及びショ糖脂肪酸エステル(商品名「DKエステル」(第一工業製薬社製)、食品添加物)をそれぞれ用いたこと以外は、実施例1と同様にして円柱型の錠剤を得た。
(Examples 2 to 6, Reference Example 1, Comparative Examples 1 to 7)
Chitosan powder, chitin powder, cellulose powder, crystalline cellulose (trade name “Comprecel” (manufactured by Fushimi Pharmaceutical Co., Ltd.), food additive) and sucrose fatty acid ester of the types and amounts shown in Tables 1-1 to 1-2 ( A cylindrical tablet was obtained in the same manner as in Example 1, except that the trade name “DK Ester” (manufactured by Daiichi Kogyo Seiyaku Co., Ltd., food additive) was used.

<評価(1)>
(硬度の測定)
錠剤硬度計(商品名「モンサント錠剤硬度計 B型」、富士理化工業社製)を使用し、錠剤を水平方向に圧縮破断する際に要した荷重(単位;kgf)を測定した。各処方につき5回測定した荷重の平均値を錠剤硬度とした。結果を表1−1〜1−2に示す。
<Evaluation (1)>
(Measurement of hardness)
Using a tablet hardness tester (trade name “Monsanto Tablet Hardness Tester Type B”, manufactured by Fuji Rika Kogyo Co., Ltd.), the load (unit: kgf) required for compressively breaking the tablet in the horizontal direction was measured. The average value of the loads measured five times for each prescription was defined as the tablet hardness. The results are shown in Tables 1-1 to 1-2.

(分散時間の測定)
100mLビーカーに37℃の水を約80mL入れ、2cmのマグネットスターラーを用いて400rpmの回転速度で撹拌した。次いで、水面から2cmの高さから錠剤を投入し、錠剤が水と接触してから、膨潤及び分散して錠剤の原形が目視で確認できなくなるまでの時間を5回測定し、その平均値を分散時間(単位:秒)とした。結果を表1−1〜1−2に示す。
(Measurement of dispersion time)
About 80 mL of water at 37 ° C. was put in a 100 mL beaker, and stirred at a rotation speed of 400 rpm using a 2 cm magnet stirrer. Next, the tablet is charged from a height of 2 cm from the water surface, and the time from when the tablet comes into contact with water until it swells and disperses and the original form of the tablet cannot be visually confirmed is measured five times. The dispersion time (unit: seconds) was used. The results are shown in Tables 1-1 to 1-2.

Figure 2019216683
Figure 2019216683

Figure 2019216683
Figure 2019216683

<評価(2)>
実施例1で製造した錠剤を舌に乗せ、上顎に軽く押し付けた。錠剤が口中で完全に分散するまでの時間を測定したところ、15秒であった。また、実施例5で製造した錠剤を舌に乗せ、上顎に軽く押し付けた。錠剤が口中で完全に分散するまでの時間を測定したところ、30秒であった。
<Evaluation (2)>
The tablet produced in Example 1 was placed on the tongue and lightly pressed against the upper jaw. The time required for the tablet to completely disperse in the mouth was determined to be 15 seconds. In addition, the tablet produced in Example 5 was placed on the tongue and lightly pressed against the upper jaw. The time it took for the tablet to completely disperse in the mouth was 30 seconds.

本発明の製造方法によって製造される錠剤は、例えば、経口用錠剤として有用である。   The tablet produced by the production method of the present invention is useful, for example, as an oral tablet.

Claims (8)

キチン及びキトサンの少なくともいずれかの粉末成分を含有するとともに、全固形分に占める前記粉末成分の割合が10質量%以上であり、
前記粉末成分の粒度が、80メッシュの篩をパスする粒度であり、
硬度が8〜30kgfである錠剤。
Containing at least one powder component of chitin and chitosan, and the proportion of the powder component in the total solid content is 10% by mass or more;
The particle size of the powder component is a particle size that passes through an 80 mesh sieve,
A tablet having a hardness of 8 to 30 kgf.
前記粉末成分が、脱アセチル化度が70%以上のキトサンの粉末である請求項1に記載の錠剤。   The tablet according to claim 1, wherein the powder component is a chitosan powder having a degree of deacetylation of 70% or more. 前記粉末成分が、セルロースの粉末をさらに含む請求項1又は2に記載の錠剤。   The tablet according to claim 1, wherein the powder component further comprises a cellulose powder. 賦形剤及び滑沢剤の少なくともいずれかをさらに含有する請求項1〜3のいずれか一項に記載の錠剤。   The tablet according to any one of claims 1 to 3, further comprising at least one of an excipient and a lubricant. 経口用錠剤である請求項1〜4のいずれか一項に記載の錠剤。   The tablet according to any one of claims 1 to 4, which is an oral tablet. 撹拌状態の37℃の水に投入してから、その原形を目視により観察できなくなるまでの時間が、120秒以内である請求項1〜5のいずれか一項に記載の錠剤。   The tablet according to any one of claims 1 to 5, wherein the time from the introduction into the stirred water at 37 ° C until the original form cannot be visually observed is within 120 seconds. 請求項1〜6のいずれか一項に記載の錠剤の製造方法であって、
80メッシュの篩をパスする粒度である、キチン及びキトサンの少なくともいずれかの粉末成分と水を混合し、下記式(1)で表される水添加率が200〜400質量%である含水原料を得る工程と、
得られた前記含水原料を乾燥及び分級して、含水率が15質量%以下である乾燥粉末を得る工程と、
得られた前記乾燥粉末を含有する成型原料を成型して錠剤を得る工程と、
を有する錠剤の製造方法。
水添加率(質量%)=(W/P)×100 ・・・(1)
P:粉末成分の量(g)
W:添加する水の量(g)
A method for producing a tablet according to any one of claims 1 to 6,
A powder containing at least one of chitin and chitosan, which has a particle size passing an 80-mesh sieve, and water are mixed, and a water-containing raw material having a water addition rate of 200 to 400% by mass represented by the following formula (1) is obtained. Obtaining,
Drying and classifying the obtained water-containing raw material to obtain a dry powder having a water content of 15% by mass or less;
A step of molding a molding material containing the obtained dry powder to obtain a tablet,
A method for producing a tablet having:
Water addition rate (% by mass) = (W / P) × 100 (1)
P: amount of powder component (g)
W: amount of water to be added (g)
前記粉末成分と前記水を混合した後、加熱条件下で撹拌して前記含水原料を得る請求項7に記載の錠剤の製造方法。   The tablet manufacturing method according to claim 7, wherein after mixing the powder component and the water, the mixture is stirred under a heating condition to obtain the water-containing raw material.
JP2018118840A 2018-06-22 2018-06-22 Tablets and their manufacturing methods Active JP6982552B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018118840A JP6982552B2 (en) 2018-06-22 2018-06-22 Tablets and their manufacturing methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018118840A JP6982552B2 (en) 2018-06-22 2018-06-22 Tablets and their manufacturing methods

Publications (2)

Publication Number Publication Date
JP2019216683A true JP2019216683A (en) 2019-12-26
JP6982552B2 JP6982552B2 (en) 2021-12-17

Family

ID=69094527

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018118840A Active JP6982552B2 (en) 2018-06-22 2018-06-22 Tablets and their manufacturing methods

Country Status (1)

Country Link
JP (1) JP6982552B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021194253A1 (en) * 2020-03-25 2021-09-30 주식회사 삼양홀딩스 Oral tablet composition of pomalidomide and method for preparing same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597117A (en) * 1982-07-02 1984-01-14 Teijin Ltd Pharmaceutical containing chitosan
JP2004262860A (en) * 2003-03-03 2004-09-24 Fancl Corp Chitosan-containing tablet and method for producing the same
JP2017066105A (en) * 2015-09-30 2017-04-06 小林製薬株式会社 Tablet comprising chitosan and/or chitin
JP2017082102A (en) * 2015-10-28 2017-05-18 日本化薬フードテクノ株式会社 Chitosan powder and method for producing the same, and chitosan containing formulation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597117A (en) * 1982-07-02 1984-01-14 Teijin Ltd Pharmaceutical containing chitosan
JP2004262860A (en) * 2003-03-03 2004-09-24 Fancl Corp Chitosan-containing tablet and method for producing the same
JP2017066105A (en) * 2015-09-30 2017-04-06 小林製薬株式会社 Tablet comprising chitosan and/or chitin
JP2017082102A (en) * 2015-10-28 2017-05-18 日本化薬フードテクノ株式会社 Chitosan powder and method for producing the same, and chitosan containing formulation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021194253A1 (en) * 2020-03-25 2021-09-30 주식회사 삼양홀딩스 Oral tablet composition of pomalidomide and method for preparing same

Also Published As

Publication number Publication date
JP6982552B2 (en) 2021-12-17

Similar Documents

Publication Publication Date Title
JP4737754B2 (en) Cellulose powder
JP5439366B2 (en) Cellulose powder excellent in segregation preventing effect and composition thereof
Iqubal et al. Recent advances in direct compression technique for pharmaceutical tablet formulation
KR102384233B1 (en) Composition comprising okra for use in reducing dietary fat absorption
JP2020048461A (en) High concentration protein beverage
TWI717605B (en) Composition for disintegrating tablets containing microfibrous cellulose and effective ingredients
JP6942342B2 (en) Soft capsule film
JP5101804B2 (en) Tablet excipients
JP5969680B1 (en) Chitosan powder, method for producing the same, and preparation containing chitosan
JP6982552B2 (en) Tablets and their manufacturing methods
JP6823620B2 (en) I Ching compression molded product and its manufacturing method
JP5578955B2 (en) Hyaluronic acid and glucosamine-containing tablets
JP6032917B2 (en) tablet
EP1721620A1 (en) Directly-compressible xylitol powder
JP6907160B2 (en) Method for manufacturing easily dispersible compression molded product
JP2004262860A (en) Chitosan-containing tablet and method for producing the same
KR20150139074A (en) Composition of adult diseases prevention food containing oat dietary fiber and Garcinia cambogia extract
JPH10509982A (en) Introduction of NSAIDs using powdered hydrocolloid rubber obtained from higher plants
Meko et al. Investigation into the use of acid modified millet (Pennisetum glaucum) starch mucilage as tablet binder
JP7023656B2 (en) Composite particles of N-acetylglucosamine and excipients
JP2021141846A (en) Composition for inhibiting hyperglycemia immediately after meals
JPWO2020022053A1 (en) Disintegrating particle composition containing fine fibrous cellulose and no excipients
US20150010621A1 (en) Sustained release solid dosage preparations
EP4255221A1 (en) Compressed tablets comprising hmo
JP6132457B2 (en) Beverages containing collagen

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210104

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210304

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210518

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210714

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20211116

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20211119

R150 Certificate of patent or registration of utility model

Ref document number: 6982552

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150